Overview

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Status:
Completed
Trial end date:
1997-06-01
Target enrollment:
Participant gender:
Summary
To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Atenolol
Diltiazem
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Nifedipine